Adam Roger Hall

Adam Roger Hall serves as Associate Professor in Biomedical Engineering at Wake Forest University School of Medicine with cross-appointments at the Wake Forest Institute for Regenerative Medicine, Center for Redox Biology and Medicine, and Comprehensive Cancer Center. His research integrates nanotechnology with biomedical diagnostics and therapeutic development.

Dr. Hall's educational background includes:

• BS from University of North Carolina, Chapel Hill (2002)
• PhD from University of North Carolina, Chapel Hill (2007)

His research focuses on DNA nanotechnology applications for cancer biomarker detection and innate immunity studies, utilizing solid-state nanopores and microfluidic systems. Key areas include:

• Cancer Biomarker Discovery
• Glycan Analysis
• Nanopore-Based DNA Sensing
• Microfluidic Drug Screening Platforms
• Epigenetic Modification Studies
• Translational Cancer Diagnostics

Recent publications (2020-2021) demonstrate consistent innovation in nanotechnology applications, particularly solid-state nanopore techniques for DNA analysis in cancer detection, affinity-labeling methods for epigenetic studies, and biomaterial development for organ-on-a-chip systems.

Dr. Hall actively participates in the Biomedical Engineering PhD Program and Biomedical Engineering Society, contributing to graduate education and professional development within the department.

His laboratory work integrates with multiple research centers including the Wake Forest Institute for Regenerative Medicine where he develops tissue engineering solutions, and the Comprehensive Cancer Center where his nanopore technologies advance early cancer detection methodologies.